國家衛生研究院 NHRI:Item 3990099045/9015

NHRI > Institute of Biotechnology and Pharmaceutical Research > John Tsu-An Hsu > Patents > Item 3990099045/9015

Please use this identifier to cite or link to this item: http://ir.nhri.org.tw/handle/3990099045/9015

Title:	Treatment of coronavirus infection
Authors:	Hsu, TA;Hsieh, HP;Chao, YS;Chen, CM;Jan, JT;Liu, HW
Contributors:	Institute of Biotechnology and Pharmaceutical Research
Abstract:	A method for treating coronavirus infection by administering to a subject in need of the treatment an effective amount of one or more of the following compounds: aklavin, sanguinarine, amiodarone, chlorpromazine, clomiphene, dihydroergotamine, dipyridamole, emetine, ephedrine, prochlorperazine, promazine, propiomazine, aminacrine, fluphenazine, fenoterol, peruvoside, proglumide, atenolol, nerifolin, nefopam, cycloheximide, avermectin B1, bepridil, cinnarizine, ethisterone, pararosaniline, methylbenzethonium, niclosamide, pipobroman, homidium, calcimycin, anisomycin, metergoline, amodiaquine, danazol, danthron, ethopropazine, eucatropine, nortriptyline, resorcinol, mebhydrolin, mebeverine, trimipramine, triflupromazine, chlorprothixene, cyclobenzaprine, enoxacin, sulfanitran, monensin, nigericin, perphenazine, methoxamine, astemizole, trifluoperazine, acriflavinium, rotenone, acebutolol, quabain, methiothepin, convallatoxin, halcinonide, cyclosporin, pimethixene, mycophenolic acid, promethazine, mesoridazine, thioridazine, chlorprothixene, thiothixene, clozapine, haloperidol, haloperidol decanoate, loxapine, molindone, olanzapine, pimozide, quetiapine, risperidone, and amitriptyline.
Date:	2009-06-09
Relation:	US7544712B1/2009-06-09
Link to:	http://worldwide.espacenet.com/publicationDetails/biblio?CC=US&NR=7544712&KC=B2
Appears in Collections:	[John Tsu-An Hsu] Patents [Hsing-Pang Hsieh] Patents [Yu-Sheng Chao(2002-2013)] Patents

Files in This Item:

There are no files associated with this item.

Loading...